Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy
Background: Matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) are regulating enzymes of the extracellular matrix. A systemic imbalance of MMP-9 and TIMP-1, thought to reflect an imbalance of the extracellular matrix homeostasis, is previously associated with po...
Main Authors: | Jakob Ø. Sørensen, Yousif Subhi, Christopher R. Molbech, Marie Krogh Nielsen, Torben L. Sørensen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Vision |
Subjects: | |
Online Access: | https://www.mdpi.com/2411-5150/4/2/27 |
Similar Items
-
Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01) -
Observation of a pulsatile choroidal vascular lesion in a patient with polypoidal choroid vasculopathy during vitrectomy
by: Ting Zhang, et al.
Published: (2022-06-01) -
Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01) -
Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
by: Zafer Öztaş, et al.
Published: (2016-08-01) -
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
by: Marta Medina-Baena, et al.
Published: (2018-03-01)